Skip to main content
. 2011 Mar 28;52(3):1762–1769. doi: 10.1167/iovs.10-6134

Figure 6.

Figure 6.

Loss of epithelial barrier–forming ability in anti-KLF4 siRNA treated cells. TEER developed by wild-type, control siRNA, or anti-KLF4 siRNA–treated HCE cells cultured on permeable supports (Transwell plates; Corning Costar) was estimated every day for 15 days, as a measure of epithelial barrier–forming ability.